Gerald Webersinke
Gerald Webersinke publishes mostly in Molecular Biology, Hematology and Pulmonary and Respiratory Medicine, on topics such as Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment and Cancer Genomics and Diagnostics.
- World rank
- #2,266,820 of 7,710,434 ranked researchers
- Rank in Austria
- #13,628 of 43,330
- Works
- 85
- Citations
- 1.5k
- Citations per work
- 18.1
What does Gerald Webersinke research?
Gerald Webersinke's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (20%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3844.7%
- Medicine3844.7%
- Everything else3035.7%
- Life Sciences1719.6%
- 1Molecular Biology14% of their works
- 2Hematology12% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Genetics11% of their works
- 5Oncology10% of their works
- 6Cancer Research6% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Acute Myeloid Leukemia Research
- Eosinophilic Disorders and Syndromes
- Epigenetics and DNA Methylation
- Chronic Lymphocytic Leukemia Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
Which keywords describe Gerald Webersinke's research?
The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, JAK2 Mutation, Myelofibrosis, Acute Myeloid Leukemia, AML and Cancer Genomics.
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Biliary Tract Cancer
- Fusion Genes
- Cancer Genomics
- AML
- JAK2 Mutation
- BCR-ABL
- Prognostic Factors
- Imatinib
- Myelofibrosis
- Acute Myeloid Leukemia
- Mutational Signatures
- Hypereosinophilic Syndrome
- Cholangiocarcinoma
- DNA Methylation
- Histone Modification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Prognostic Factors253 topics
- BCR-ABL161 topic
- Imatinib161 topic
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- AML111 topic
- Acute Myeloid Leukemia111 topic
- Cancer Genomics111 topic
- Mutational Signatures111 topic
- Fusion Genes81 topic
- Hypereosinophilic Syndrome81 topic
- Biliary Tract Cancer71 topic
- Cholangiocarcinoma71 topic
- Chronic Lymphocytic Leukemia71 topic
- DNA Methylation71 topic
- Genomic Aberrations71 topic
- Histone Modification71 topic
Where does Gerald Webersinke work?
Gerald Webersinke's main affiliation in the publication record is AGO Austria, Austria.
How many publications and citations does Gerald Webersinke have?
OpenAlex counts 85 works and 1,538 citations for Gerald Webersinke, an h-index of 21, ranking #2,266,820 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gerald Webersinke. Posts are plain text and can be reported.